Ajanta Pharma shares up 2% on launch of anti-dementia drug in US

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Moneycontrol Bureau

Ajanta Pharma shares gained 2 percent intraday Tuesday after its subsidiary has launched Memantine hydrochloride tablets in the US.

Memantine hydrochloride is an anti-dementia drug and is a bioequivalent generic version of Namenda.

Ajanta said it has launched the drug in two strengths 5mg and 10mg tablets.

So far, United States Food & Drug Administration has granted Ajanta Pharma 10 final approvals and 2 tentative approvals for its abbreviated new drug application, it said, adding another 14 ANDAs are pending approval from the USFDA.

At 11:27 hours IST, the scrip of Ajanta Pharma was quoting at Rs 1,589.10, up Rs 27.85, or 1.78 percent on Bombay Stock Exchange.Posted by Sunil Shankar Matkar